Research progress of neurotransmitters in lung injury after traumatic brain injury.
10.3760/cma.j.cn121430-20250430-00416
- Author:
Le CAO
1
;
Haikun ZHANG
1
;
Jinxiang YU
1
;
Pengcheng MA
1
;
Lifeng JIA
1
;
Tao ZHAO
1
Author Information
1. School of Anesthesiology, Shandong Second University, Weifang 261053, China.
- Publication Type:English Abstract
- MeSH:
Humans;
Brain Injuries, Traumatic/metabolism*;
Neurotransmitter Agents/metabolism*;
Lung Injury/metabolism*;
gamma-Aminobutyric Acid/metabolism*;
Glutamic Acid/metabolism*;
Norepinephrine/metabolism*;
Dopamine/metabolism*;
Acetylcholine/metabolism*
- From:
Chinese Critical Care Medicine
2025;37(10):982-988
- CountryChina
- Language:Chinese
-
Abstract:
Traumatic brain injury (TBI), as a significant central nervous system damage disease with high frequency in the world, leads to a huge number of patients with impaired health and lower quality of life every year. Lung injury is a common and dangerous consequence, which dramatically raises the mortality of patients. Discovering the pathophysiology of lung injury after TBI and discovering viable therapeutic targets has become an important need for clinical diagnosis and therapy. Neurotransmitters, as the fundamental chemical agents of the nervous system for signal transmission, not only govern neuronal activity and apoptosis in TBI but also significantly influence the pathophysiological mechanisms of lung injury subsequent to TBI. The imbalance is intricately linked to the onset and progression of lung damage. This paper systematically reviews the clinical characteristics and predominant pathogenesis of lung injury following TBI, emphasizing the role of key neurotransmitters, including glutamate (Glu), γ-aminobutyric acid (GABA), norepinephrine (NE), dopamine (DA), and acetylcholine (ACh), in lung injury post-TBI. It examines their influence on inflammatory response, vascular permeability, and pulmonary circulation function. Additionally, the paper evaluates the research advancements and potential applications of targeted therapeutic strategies for various neurotransmitter systems, such as receptor antagonists, transporter inhibitors, and neurotransmitter analogues. This research aims to offer a theoretical framework for clarifying the neural regulatory mechanisms of lung injury following TBI and to establish a basis for the development of novel therapeutic strategies and enhancement of the prognosis of the patients.
